- Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop CNBC
- Pill Causes Major Weight Loss in Eli Lilly Trial’s Results The New York Times
- Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity Eli Lilly and Company
Brought to you by Google News. Read the rest of the article here